Checkpoint Inhibitor-Associated Vogt-Koyanagi-Harada Disease Presenting 3 Months Following Discontinuation of Nivolumab
The use of checkpoint inhibitors has been associated with multiple ocular and orbital complications including Vogt-Koyanagi-Harada disease. In the current case, a 55-year-old man presented with visual changes 3 months following discontinuation of nivolumab for metastatic renal cell carcinoma. This i...
Description complète
Détails bibliographiques
| Publié dans: | Ophthalmic surgery, lasers & imaging retina. - 2013. - 54(2023), 3 vom: 28. März, Seite 183-187
|
|---|
| Auteur principal: |
Tieger, Marisa Gobuty
(Auteur) |
|---|
| Autres auteurs: |
Eliott, Dean,
Cakir, Bertan,
Dahrouj, Mohammad |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2023
|
|---|
| Accès à la collection: | Ophthalmic surgery, lasers & imaging retina
|
|---|
| Sujets: | Case Reports
Journal Article
Nivolumab
31YO63LBSN
Immune Checkpoint Inhibitors |
|---|